Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Mar;18(2S):S3-S10.
doi: 10.1016/j.acap.2017.09.014.

Ten Years of Human Papillomavirus Vaccination in the United States

Lauri E Markowitz  1 , Julianne Gee  2 , Harrell Chesson  3 , Shannon Stokley  4
Affiliations
Review

Ten Years of Human Papillomavirus Vaccination in the United States

Lauri E Markowitz et al. Acad Pediatr. 2018 Mar.

Abstract

Since human papillomavirus (HPV) vaccine was first introduced for females in the United States in 2006, vaccination policy has evolved as additional HPV vaccines were licensed and new data became available. The United States adopted a gender neutral routine HPV immunization policy in 2011, the first country to do so. Vaccination coverage is increasing, although it remains lower than for other vaccines recommended for adolescents. There are various reasons for low coverage, and efforts are ongoing to increase vaccine uptake. The safety profile of HPV vaccine has been well established from 10 years of postlicensure monitoring. Despite low coverage, the early effects of the HPV vaccination program have exceeded expectations.

Keywords: human papillomavirus; human papillomavirus vaccine; immunization program.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure.
Figure.
Estimated vaccination coverage among adolescents aged 13 to 17 years, National Immunization Survey-Teen, United States, 2006 through 2016. Coverage on the basis of provider records; a revised definition of adequate provider data was used starting in 2013. HPV indicates human papillomavirus vaccine; Tdap, tetanus, diphtheria, and acellular pertussis vaccine; and MenACWY, meningococcal ACWY vaccine.
See this image and copyright information in PMC

References

    1. Forman D, de Martel C, Lacey CJ, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30(suppl 5): F12–F23. - PubMed
    1. Centers for Disease Control and Prevention. Number of HPV-associated cancer cases per year. Available at: https://www.cdc.gov/cancer/hpv/statistics/cases.htm. Accessed August 10, 2017.
    1. Saraiya M, Unger ER, Thompson TD, et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst. 2015;107:djv086. - PMC - PubMed
    1. Schiller JT, Castellsague X, Garland SM. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine. 2012;30(suppl 5):F123–F138. - PMC - PubMed
    1. Markowitz LE, Dunne EF, Saraiya M, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2014;63:1–30. - PubMed

Publication types

MeSH terms

Substances